Excipient lung disease secondary to intravenous heroin use.
Saved in:
| Title: | Excipient lung disease secondary to intravenous heroin use. |
|---|---|
| Authors: | Colbenson GA; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Kubbara A; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA., Cox CW; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Yi ES; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA., Baqir M; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA baqir.misbah@mayo.edu. |
| Source: | BMJ case reports [BMJ Case Rep] 2022 Apr 21; Vol. 15 (4). Date of Electronic Publication: 2022 Apr 21. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35450874 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Excipient lung disease secondary to intravenous heroin use. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Colbenson+GA%22">Colbenson GA</searchLink>; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Kubbara+A%22">Kubbara A</searchLink>; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Cox+CW%22">Cox CW</searchLink>; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Yi+ES%22">Yi ES</searchLink>; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Baqir+M%22">Baqir M</searchLink>; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA baqir.misbah@mayo.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101526291%22">BMJ case reports</searchLink> [BMJ Case Rep] 2022 Apr 21; Vol. 15 (4). <i>Date of Electronic Publication: </i>2022 Apr 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Pub%2E+Group%22">BMJ Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101526291 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-790X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221757790X%22">1757790X </searchLink><i>NLM ISO Abbreviation: </i>BMJ Case Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35450874 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/bcr-2021-247763 Languages: – Code: eng Text: English Titles: – TitleFull: Excipient lung disease secondary to intravenous heroin use. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Colbenson GA – PersonEntity: Name: NameFull: Kubbara A – PersonEntity: Name: NameFull: Cox CW – PersonEntity: Name: NameFull: Yi ES – PersonEntity: Name: NameFull: Baqir M IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 04 Text: 2022 Apr 21 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1757-790X Numbering: – Type: volume Value: 15 – Type: issue Value: 4 Titles: – TitleFull: BMJ case reports Type: main |
| ResultId | 1 |
